Literature DB >> 33971180

Advantages and disadvantages of disulfiram coadministered with popular addictive substances.

Patrycja Kleczkowska1, Dorota Sulejczak2, Malgorzata Zaremba3.   

Abstract

Disulfiram (DSF) is a well-known anti-alcohol agent that inhibits aldehyde dehydrogenase and results in extreme 'hangover' symptoms when consumed with alcohol This drug, however, has been suggested as useful in other forms of drug addiction due to its beneficial potential in both drug abuse reduction and withdrawal However, among other drugs used in alcohol dependence, it carries the greatest risk of pharmacological interactions Concomitant use of DSF and central nervous system stimulants usually leads to harmful, undesirable effects To date, there is still limited data regarding the detailed safety profile of DSF as a concomitant drug In this review article, we outline the current state of knowledge about DSF, its broad pharmacological action, as well as therapeutic effects, with a particular emphasis on the molecular understanding of its potential pharmacodynamic interactions with common addictive substances (eg, alcohol, cocaine, cannabinoids, opioids) supported by relevant examples.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Addiction; Disulfiram; Drug abuse; Interaction; Toxicity

Year:  2021        PMID: 33971180     DOI: 10.1016/j.ejphar.2021.174143

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

1.  Phase II study of Disulfiram and Cisplatin in Refractory Germ Cell Tumors. The GCT-SK-006 phase II trial.

Authors:  M Mego; D Svetlovska; K Kalavska; P Lesko; M Makovník; J Obertova; Z Orszaghova; P Palacka; M Rečková; K Rejlekova; Sycova-Mila Z; J Mardiak; M Chovanec
Journal:  Invest New Drugs       Date:  2022-06-28       Impact factor: 3.651

2.  Six Types of Tea Reduce Acute Alcoholism in Mice by Enhancing Ethanol Metabolism, Suppressing Oxidative Stress and Inflammation.

Authors:  Xingfei Lai; Xinrong Wang; Shuai Wen; Lingli Sun; Ruohong Chen; Zhenbiao Zhang; Qiuhua Li; Junxi Cao; Zhaoxiang Lai; Zhigang Li; Shili Sun; Xiaohui Liu
Journal:  Front Nutr       Date:  2022-05-23

3.  Increased Fibrosis in a Mouse Model of Anti-Laminin 332 Mucous Membrane Pemphigoid Remains Unaltered by Inhibition of Aldehyde Dehydrogenase.

Authors:  Sabrina Patzelt; Manuela Pigors; Heiko Steenbock; Leonard Diel; Katharina Boch; Lenche Chakievska; Sven Künzel; Hauke Busch; Anke Fähnrich; Jürgen Brinckmann; Enno Schmidt
Journal:  Front Immunol       Date:  2022-02-07       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.